Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients

Yuri Sakane, Masahiko Yamaguchi, Atsushi Shiraishi

Journal of Ophthalmology · 2019 · 13 citations · 31 references

DOIFull text

Open access

Abstract

RBM treatment improves the QOL by alleviating the corneal and conjunctival epithelial damages. The DEQS is a useful questionnaire that can assess the severity of the DED symptoms and their impact on the QOL. This trial is registered with UMIN000024405.

References

31